BJP College Seminars Series
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chong, S.-A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chong, S.-A.
The British Journal of Psychiatry (2001) 178: 179-180
© 2001 The Royal College of Psychiatrists


Correspondence

Psychotropic drugs and sudden death

S.-A. Chong

Institute of Mental Health and Woodbridge Hospital, 10 Buangkok View, Singapore 539747, Singapore

EDITED BY MATTHEW HOTOPF

In their editorial, Appleby et al (2000) indicated that the mechanism of sudden death among patients taking antipsychotic medications might be ventricular arrhythmias and that QTc prolongation might be a particularly important harbinger of these events.

Another electrocardiographic sign (without prolonged QTc) that may be associated with sudden death from ventricular fibrillation is the Brugada sign (i.e. right bundle branch block and elevation of the ST segment; Brugada & Brugada, 1992). Buckley & Sanders (2000) have commented that although no specific antipsychotic has been directly associated with the Brugada sign (unlike the tricyclic antidepressants), anti-psychotic medications with the capacity to block sodium channels may precipitate this and possibly lead to sudden death.

In addition to the risk factors mentioned, drug-drug interaction is an important consideration. Drugs like the tricyclic antidepressants and lithium, with their propensity to prolong the QT interval, may have a synergistic additive effect when combined with an antipsychotic medication. Inhibition of the cytochrome P450 enzymes involved in the metabolism of psychotropic drugs leads to increased blood levels, and prolongation of the QT interval in individuals taking antipsychotic medications such as haloperidol, sertindole, risperidone and olanzapine occurs in a concentration-related manner (Drici et al, 1998). Certain selective serotonin reuptake inhibitors (fluvoxamine, paroxetine) are potent inhibitors of some of these cytochrome P450 enzymes. Grapefruit juice, although seemingly innocuous, has attained some notoriety from its association with prolonged QT intervals in individuals taking terfenadine and has been implicated in one death (Jefferson, 1998). Grapefruit juice is a potent inhibitor of the P450 CYP1A2, 2A6 and 3A4 enzymes, which are important in the metabolism of clozapine, amitriptyline, imipramine and clomipramine. Clinicians should therefore be mindful of these interactions and give the appropriate warning to their patients taking these medications.

REFERENCES

Appley, L., Thomas, S., Ferrier, N., et al (2000) Sudden unexplained death in psychiatric in-patients. British Journal of Psychiatry, 176, 405-406.[Free Full Text]

Brugada, P. & Brugada, J. (1992) Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. Journal of the American College of Cardiology, 20, 1391-1396.[Abstract]

Buckley, N. A. & Sanders, P. (2000) Cardiovascular adverse effects of antipsychotic drugs. Drug Safety, 23, 215-228.[CrossRef][Medline]

Drici, M. D., Wang, W. X., Liu X. E., et al (1998) Prolongation of QT interval in isolated feline hearts by antipsychotic drugs. Journal of Clinical Psychopharmacology, 18, 477-481.[CrossRef][Medline]

Jefferson, J. W. (1998) Drug and diet interactions; avoiding therapeutics paralysis. Journal of Clinical Psychiatry, 59 (suppl. 16), 31-39.




This article has been cited by other articles:


Home page
Br. J. PsychiatryHome page
C. H. Cantor
Evolution, biological reductionism and closed minds
The British Journal of Psychiatry, October 1, 2001; 179 (4): 370 - 371.
[Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
S. Rose and P. Lucas
Evolutionary psychology revisited
The British Journal of Psychiatry, June 1, 2001; 178 (6): 573 - 573.
[Full Text]


This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chong, S.-A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chong, S.-A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals